Cannabidiol/tetrahydrocannabinol - Axim Biotech

Drug Profile

Cannabidiol/tetrahydrocannabinol - Axim Biotech

Alternative Names: CBD/THC gum; MedChew 1401; MedChew 1502; MedChew 1503; MedChew 1504; MedChew GP; MedChew Rx; MedChew-RL; Tetrahydrocannabinol/cannabidiol - Axim Biotech

Latest Information Update: 23 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Axim Biotech
  • Class Analgesics; Antiemetics; Anxiolytics; Appetite stimulants; Cannabinoids; Muscle relaxants; Neuroprotectants; Phytotherapies
  • Mechanism of Action Cannabinoid receptor CB1 antagonists; Cannabinoid receptor CB2 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Dementia; Pain; Parkinson's disease; Restless legs syndrome
  • Preclinical Postherpetic neuralgia

Most Recent Events

  • 22 Aug 2017 AXIM Biotech plans a clinical trial for Postherpetic neuralgia
  • 23 Mar 2017 Preclinical trials in Postherpetic neuralgia in USA (Buccal) (Axim Biotech pipeline, March 2017)
  • 16 Nov 2016 Axim Biotech receives patent allowance for cannabinoid-containing controlled-release chewing gum products in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top